Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Julphar
Fuji
Citi
Teva

Generated: September 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MIDOL LIQUID GELS

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Midol Liquid Gels

Trial ID Title Status Sponsor Phase Summary
NCT00000140 The Silicone Study Completed National Eye Institute (NEI) Phase 3 To compare, through a randomized, multicenter surgical trial, the postoperative tamponade effectiveness of intraocular silicone oil with that of an intraocular long-acting gas (initially sulfur hexafluoride [SF 6 ], later perfluoropropane [C 3 F 8 ]) for the management of retinal detachment complicated by proliferative vitreoretinopathy (PVR), using vitrectomy and associated techniques. To evaluate the ocular complications that result from the use of silicone oil and gas.
NCT00000302 Study Comparing Liquid and Tablet Buprenorphine Formulations - 5 Completed National Institute on Drug Abuse (NIDA) Phase 3 The purpose of this study is to compare liquid and tablet buprenorphine formulations.
NCT00000320 Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Completed National Institute on Drug Abuse (NIDA) Phase 1/Phase 2 The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."
NCT00000341 Evaluation of Liquid vs. Tablet Buprenorphine - 6 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.
>Trial ID >Title >Status >Phase >Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Midol Liquid Gels

Condition Name

Condition Name for Midol Liquid Gels
Intervention Trials
Healthy 63
HIV Infections 19
Cystic Fibrosis 19
Breast Cancer 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Midol Liquid Gels
Intervention Trials
Diabetes Mellitus 41
Infection 33
Diabetes Mellitus, Type 2 32
HIV Infections 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Midol Liquid Gels

Trials by Country

Trials by Country for Midol Liquid Gels
Location Trials
Canada 130
United Kingdom 86
Germany 67
France 58
Spain 54
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Midol Liquid Gels
Location Trials
California 125
Texas 106
Maryland 82
New York 82
Ohio 73
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Midol Liquid Gels

Clinical Trial Phase

Clinical Trial Phase for Midol Liquid Gels
Clinical Trial Phase Trials
Phase 4 193
Phase 3 130
Phase 2/Phase 3 30
[disabled in preview] 232
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Midol Liquid Gels
Clinical Trial Phase Trials
Completed 566
Recruiting 188
Not yet recruiting 132
[disabled in preview] 64
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Midol Liquid Gels

Sponsor Name

Sponsor Name for Midol Liquid Gels
Sponsor Trials
National Cancer Institute (NCI) 69
M.D. Anderson Cancer Center 23
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Midol Liquid Gels
Sponsor Trials
Other 1032
Industry 498
NIH 178
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Colorcon
Deloitte
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.